British drugs giant AstraZeneca on Monday rejected a final takeover bid from US rival Pfizer worth $117 billion, saying it undervalued the firm. Pfi...
via The Standard - Breaking News http://ift.tt/1lDEES6
via The Standard - Breaking News http://ift.tt/1lDEES6
No comments:
Post a Comment